Announcement of calls on unpaid shares of 2022 cash capital increase

1.Date of occurrence of the event:2022/03/17
2.Company name:OBI Pharma Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:Not applicable
5.Cause of occurrence:The payment period for subscription of the Company’s cash capital increase ends on 2022/3/17. The Company makes a call on the shareholders who do not complete the payment before the end of the payment period.
(1)Pursuant to Article 142, which applies mutatis mutandis to Article 266, Paragraph 3 of the Company Act, the call period of payment is from 2022/3/18 to 2022/4/18 15:30. For shareholders who haven’t paid up for subscription, please complete the payment pursuant to the regulation of share subscription form. The shareholders shall forfeit their rights if they fail to pay within the call period.
(2)After the end of the call period and TDCC finishes processing the procedure, the shares will be deposited in the depository account according to the number of shares subscribed for shareholders who pay within the call period.
(3)If there is any question, please contact transfer agent of the Company, Masterlink Securities (Address: B1., No. 35, Ln. 11, Guangfu N. Rd., Songshan Dist., Taipei City 105410, Taiwan / TEL:02-2768-6668)
7.Any other matters that need to be specified:None